The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cognitive Impairment in Older Adults
Abstract
Cognitive impairment and dementia affect dozens of millions of people worldwide and cause significant distress to patients and caregivers and a financial burden to families and health care systems. Careful history-taking, cognitive and physical examination, and supplemental neuroimaging and fluid-based biomarkers can accurately diagnose neurocognitive disorders. Management includes non-pharmacological and pharmacological treatments tailored to the etiology and to the individual.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedMcKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Caregiver Burden: A Clinical Review
Adelman, R. D., Tmanova, L. L., Delgado, D., Dion, S., & Lachs, M. S. (2014) · JAMA · doi:10.1001/jama.2014.304 · Cited by 2,002
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Research works printed but not linked: 81
- Anderson, 2019, State of the science on mild cognitive impairment (MCI), CNS Spectr, 24, 78, 10.1017/S1092852918001347 · DOI · Paper page
- Petersen, 2018, Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology, Neurology, 90, 126, 10.1212/WNL.0000000000004826 · DOI · Paper page
- Sanford, 2017, Mild cognitive impairment, Clin Geriatr Med, 33, 325, 10.1016/j.cger.2017.02.005 · DOI · Paper page
- Kramarow, 2019, Dementia mortality in the United States, 2000-2017, Natl Vital Stat Rep, 68, 1
- 2021, 2021 Alzheimer’s disease facts and figures, Alzheimers Dement J Alzheimers Assoc, 17, 327, 10.1002/alz.12328 · DOI · Paper page
- Akarsu, 2019, Depression in carers of people with dementia from a minority ethnic background: Systematic review and meta-analysis of randomised-controlled trials of psychosocial interventions, Int J Geriatr Psychiatry, 34, 790, 10.1002/gps.5070 · DOI
- Arvanitakis, 2019, Diagnosis and management of dementia: review, JAMA, 322, 1589, 10.1001/jama.2019.4782 · DOI · Paper page
- Hugo, 2014, Dementia and cognitive impairment: epidemiology, diagnosis, and treatment, Clin Geriatr Med, 30, 421, 10.1016/j.cger.2014.04.001 · DOI · Paper page
- Hogan, 2016, The prevalence and incidence of dementia with Lewy bodies: a systematic review, Can J Neurol Sci J Can Sci Neurol, 43, S83, 10.1017/cjn.2016.2 · DOI · Paper page
- Leroy, 2021, Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network, Alzheimers Res Ther, 13, 19, 10.1186/s13195-020-00753-9 · DOI
- Young, 2018, Frontotemporal dementia: latest evidence and clinical implications, Ther Adv Psychopharmacol, 8, 33, 10.1177/2045125317739818 · DOI · Paper page
- Vann Jones, 2014, The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies, Psychol Med, 44, 673, 10.1017/S0033291713000494 · DOI · Paper page
- Zaccai, 2005, A systematic review of prevalence and incidence studies of dementia with Lewy bodies, Age Ageing, 34, 561, 10.1093/ageing/afi190 · DOI · Paper page
- Aarsland, 2005, A systematic review of prevalence studies of dementia in Parkinson’s disease, Mov Disord Off J Mov Disord Soc, 20, 1255, 10.1002/mds.20527 · DOI · Paper page
- Svenningsson, 2012, Cognitive impairment in patients with Parkinson’s disease: diagnosis, biomarkers, and treatment, Lancet Neurol, 11, 697, 10.1016/S1474-4422(12)70152-7 · DOI · Paper page
- Kane, 2018, Clinical prevalence of Lewy body dementia, Alzheimers Res Ther, 10, 19, 10.1186/s13195-018-0350-6 · DOI · Paper page
- Avila, 2021, Education differentially contributes to cognitive reserve across racial/ethnic groups, Alzheimers Dement, 17, 70, 10.1002/alz.12176 · DOI
- Elkana, 2020, Is the cutoff of the MoCA too High? longitudinal data from highly educated older adults, J Geriatr Psychiatry Neurol, 33, 155, 10.1177/0891988719874121 · DOI
- Cao, 2012, Comparison of the saint louis university mental status examination, the mini-mental state examination, and the montreal cognitive assessment in detection of cognitive impairment in chinese elderly from the geriatric department, J Am Med Dir Assoc, 13, 626, 10.1016/j.jamda.2012.05.003 · DOI
- Cummings-Vaughn, 2014, Veterans affairs saint louis university mental status examination compared with the montreal cognitive assessment and the short test of mental status, J Am Geriatr Soc, 62, 1341, 10.1111/jgs.12874 · DOI
- Silva, 2018, Olfactory dysfunction in Alzheimer’s disease Systematic review and meta-analysis, Dement Neuropsychol, 12, 123, 10.1590/1980-57642018dn12-020004 · DOI
- Carnemolla, 2020, Olfactory dysfunction in frontotemporal dementia and psychiatric disorders: a systematic review, Neurosci Biobehav Rev, 118, 588, 10.1016/j.neubiorev.2020.08.002 · DOI
- Staffaroni, 2017, Neuroimaging in dementia, Semin Neurol, 37, 510, 10.1055/s-0037-1608808 · DOI · Paper page
- Gauthier, 2010, Management of behavioral problems in Alzheimer’s disease, Int Psychogeriatr, 22, 346, 10.1017/S1041610209991505 · DOI · Paper page
- Johnson, 2013, Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association, Alzheimers Dement J Alzheimers Assoc, 9, e-1
- Masters, 2015, Alzheimer’s disease, Nat Rev Dis Primer, 1, 15056, 10.1038/nrdp.2015.56 · DOI · Paper page
- Zhu, 2015, Rate of early onset Alzheimer’s disease: a systematic review and meta-analysis, Ann Transl Med, 3, 38
- Rentería, 2020, Genetic testing for Alzheimer’s disease: trends, challenges and ethical considerations, Curr Opin Psychiatry, 33, 136, 10.1097/YCO.0000000000000573 · doi:10.1097/yco.0000000000000573
- Jellinger, 2010, Is there pure vascular dementia in old age?, J Neurol Sci, 299, 150, 10.1016/j.jns.2010.08.038 · DOI
- Reed, 2007, Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease, Brain J Neurol, 130, 731, 10.1093/brain/awl385 · DOI · Paper page
- Graff-Radford, 2019, Vascular cognitive impairment, Contin Minneap Minn, 25, 147
- Baezner, 2008, Association of gait and balance disorders with age-related white matter changes: the LADIS study, Neurology, 70, 935, 10.1212/01.wnl.0000305959.46197.e6 · DOI · Paper page
- Schmidt, 2012, White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations, Stroke, 43, 2643, 10.1161/STROKEAHA.112.662593 · DOI
- Salmon, 2007, Neuropsychology of cortical versus subcortical dementia syndromes, Semin Neurol, 27, 7, 10.1055/s-2006-956751 · DOI
- Charidimou, 2012, Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis, Stroke, 43, 2324, 10.1161/STROKEAHA.112.657759 · DOI · Paper page
- Revesz, 2009, Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies, Acta Neuropathol (Berl), 118, 115, 10.1007/s00401-009-0501-8 · DOI · Paper page
- Tomidokoro, 2010, Iowa variant of familial Alzheimer’s disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits, Am J Pathol, 176, 1841, 10.2353/ajpath.2010.090636 · DOI
- Zhang-Nunes, 2006, The cerebral beta-amyloid angiopathies: hereditary and sporadic, Brain Pathol Zurich Switz, 16, 30, 10.1111/j.1750-3639.2006.tb00559.x · DOI · Paper page
- Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
- Montembeault, 2018, Clinical, anatomical, and pathological features in the three variants of primary progressive aphasia: a review, Front Neurol, 9, 692, 10.3389/fneur.2018.00692 · DOI · Paper page
- Villarejo-Galende, 2017, Amyloid pet in primary progressive aphasia: case series and systematic review of the literature, J Neurol, 264, 121
- Chow, 1999, Inheritance of frontotemporal dementia, Arch Neurol, 56, 817, 10.1001/archneur.56.7.817 · DOI · Paper page
- Goldman, 2005, Comparison of family histories in FTLD subtypes and related tauopathies, Neurology, 65, 1817, 10.1212/01.wnl.0000187068.92184.63 · DOI · Paper page
- Seelaar, 2008, Distinct genetic forms of frontotemporal dementia, Neurology, 71, 1220, 10.1212/01.wnl.0000319702.37497.72 · DOI · Paper page
- Sezgin, 2019, Parkinson’s disease dementia and Lewy body disease, Semin Neurol, 39, 274, 10.1055/s-0039-1678579 · DOI
- Hamilton, 2012, Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy Bodies, Am J Geriatr Psychiatry, 20, 773, 10.1097/JGP.0b013e31823033bc · DOI
- Postuma, 2009, Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder, Neurology, 72, 1296, 10.1212/01.wnl.0000340980.19702.6e · DOI · Paper page
- Day, 2022, Aducanumab use in symptomatic Alzheimer disease evidence in focus: a report of the AAN guidelines subcommittee, Neurology, 98, 619, 10.1212/WNL.0000000000200176 · DOI
- Cooper, 2013, Treatment for mild cognitive impairment: systematic review, Br J Psychiatry J Ment Sci, 203, 255, 10.1192/bjp.bp.113.127811 · DOI · Paper page
- Raschetti, 2007, Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials, PLoS Med, 4, e338, 10.1371/journal.pmed.0040338 · DOI · Paper page
- Cheng, 2016, B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia, Nutr Neurosci, 19, 461, 10.1179/1476830514Y.0000000136 · DOI
- Li, 2014, Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis, Curr Alzheimer Res, 11, 844
- Krause, 2015, Effect of vitamin intake on cognitive decline in older adults: evaluation of the evidence, J Nutr Health Aging, 19, 745, 10.1007/s12603-015-0539-3 · DOI
- Snitz, 2009, Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial, JAMA, 302, 2663, 10.1001/jama.2009.1913 · DOI · Paper page
- Naeini, 2014, The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial, Eur J Nutr, 53, 1255, 10.1007/s00394-013-0628-1 · DOI
- Singh, 2014, Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis, J Alzheimers Dis JAD, 39, 271, 10.3233/JAD-130830 · DOI · Paper page
- Kheirouri, 2021, MIND diet and cognitive performance in older adults: a systematic review, Crit Rev Food Sci Nutr, 1
- Hosking, 2019, MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study, Alzheimers Dement J Alzheimers Assoc, 15, 581, 10.1016/j.jalz.2018.12.011 · DOI · Paper page
- Nuzum, 2020, Potential benefits of physical activity in MCI and dementia, Behav Neurol, 2020, 7807856, 10.1155/2020/7807856 · DOI · Paper page
- Altschul, 2020, Playing analog games is associated with reduced declines in cognitive function: a 68-year longitudinal cohort study, J Gerontol Ser B, 75, 474, 10.1093/geronb/gbz149 · DOI
- Rai, 2018, Cognitive stimulation therapy for dementia, Clin Geriatr Med, 34, 653, 10.1016/j.cger.2018.06.010 · DOI
- Gomez-Soria, 2020, Cognitive stimulation program in mild cognitive impairment a randomized controlled trial, Dement Neuropsychol, 14, 110, 10.1590/1980-57642020dn14-020003 · DOI
- Cummings, 2019, Treatment combinations for Alzheimer’s disease: current and future pharmacotherapy options, J Alzheimers Dis JAD, 67, 779, 10.3233/JAD-180766 · DOI · Paper page
- Schmidt, 2015, EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease, Eur J Neurol, 22, 889, 10.1111/ene.12707 · DOI · Paper page
- Matsunaga, 2015, Combination therapy with cholinesterase inhibitors and memantine for Alzheimer’s disease: a systematic review and meta-analysis, Int J Neuropsychopharmacol, 18, pyu115, 10.1093/ijnp/pyu115 · DOI
- Battle, 2021, Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis, Cochrane Database Syst Rev, 2, CD013306
- Sivasathiaseelan, 2019, Frontotemporal dementia: a clinical review, Semin Neurol, 39, 251, 10.1055/s-0039-1683379 · DOI
- Wang, 2015, Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis, J Neurol Neurosurg Psychiatr, 86, 135, 10.1136/jnnp-2014-307659 · DOI · Paper page
- Taylor, 2020, New evidence on the management of Lewy body dementia, Lancet Neurol, 19, 157, 10.1016/S1474-4422(19)30153-X · DOI · Paper page
- Cheng, 2014, Mental and physical activities delay cognitive decline in older persons with dementia, Am J Geriatr Psychiatry, 22, 63, 10.1016/j.jagp.2013.01.060 · DOI · Paper page
- Hoffmann, 2016, Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial, J Alzheimers Dis JAD, 50, 443, 10.3233/JAD-150817 · DOI · Paper page
- Wang, 2007, Group reminiscence therapy for cognitive and affective function of demented elderly in Taiwan, Int J Geriatr Psychiatry, 22, 1235, 10.1002/gps.1821 · DOI · Paper page
- Lam, 2020, Effects of music therapy on patients with dementia-a systematic review, Geriatr Basel Switz, 5, E62, 10.3390/geriatrics5040062 · DOI
- Emblad, 2021, Creative art therapy as a non-pharmacological intervention for dementia: a systematic review, J Alzheimers Dis Rep, 5, 353
- Laakkonen, 2016, Effects of self-management groups for people with dementia and their spouses--randomized controlled trial, J Am Geriatr Soc, 64, 752, 10.1111/jgs.14055 · DOI
- Widera, 2011, Finances in the older patient with cognitive impairment: “He didn’t want me to take over, JAMA, 305, 698, 10.1001/jama.2011.164 · DOI
- Yunusa, 2019, Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis, JAMA Netw Open, 2, e190828, 10.1001/jamanetworkopen.2019.0828 · DOI · Paper page
- Tampi, 2020, Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm, Neurodegener Dis Manag, 10, 5, 10.2217/nmt-2019-0036 · DOI
- Chen, 2021, The psychopharmacology algorithm project at the harvard south shore program: an update on management of behavioral and psychological symptoms in dementia, Psychiatry Res, 295, 113641, 10.1016/j.psychres.2020.113641 · DOI
- Davies, 2018, Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia, J Psychopharmacol Oxf Engl, 32, 509, 10.1177/0269881117744996 · DOI
- McCollum, 2020, Cognitive Impairment Evaluation and Management, Med Clin North Am, 104, 807, 10.1016/j.mcna.2020.06.007 · DOI
Cited by
Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies
Wang, Y., Wu, Z., Duan, L., Liu, S., Chen, R., Sun, T., Wang, J., Zhou, J., Wang, H., & Huang, P. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05026-w · Cited by 55
Metadata
- Authors
- Pérez Palmer, N., Trejo Ortega, B., & Joshi, P.
- Venue
- Psychiatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 45
- Issue
- 4
- Pages
- 639-661
- ISSN
- 0193-953X (ISSN-L)
- OpenAlex
- W4306177210
- Cited by
- 177
- References
- 42
- FWCI
- 19.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive Impairment in Older Adults. https://app.cochat.ai/papers/10.1016/j.psc.2022.07.010
- The paper
- Pérez Palmer, N., Trejo Ortega, B., & Joshi, P. (2022). Cognitive Impairment in Older Adults. Psychiatric Clinics of North America. https://doi.org/10.1016/j.psc.2022.07.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.